Literature DB >> 15356067

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.

Francesco Orio1, Stefano Palomba, Teresa Cascella, Biagio De Simone, Sebastiano Di Biase, Tiziana Russo, Donato Labella, Fulvio Zullo, Gaetano Lombardi, Annamaria Colao.   

Abstract

The aim of this study was to evaluate the presence of early vascular damage in young normal-weight women with polycystic ovary syndrome (PCOS). Thirty young normal-weight women with PCOS, who had no additional metabolic or cardiovascular diseases, and 30 healthy women (controls) matched for age and body mass index were studied. A complete hormonal assay was performed in each subject. Serum insulin and glucose levels were measured at baseline and after the oral glucose tolerance test. Plasma endothelin-1 levels and serum lipid profile were also assessed. The endothelial function was studied by flow-mediated dilation on the brachial artery, and arterial structure was evaluated by intima-media thickness measurement using Doppler ultrasound of both common carotid arteries.A significant (P < 0.05) difference in flow-mediated dilation (14.3 +/- 1.9% vs. 18.1 +/- 2.0% for PCOS patients and controls, respectively) and in intima-media thickness (0.53 +/- 0.09 mm vs. 0.39 +/- 0.08 mm for PCOS patients and controls, respectively) was found between PCOS and control subjects. Serum endothelin-1 levels were also significantly (P < 0.05) higher in PCOS patients compared with controls (1.1 +/- 0.4 pmol/liter vs. 0.5 +/- 0.2 pmol/liter for PCOS patients and controls, respectively).In conclusion, our data show that young, normal-weight, nondyslipidemic, nonhypertensive women with PCOS have an early impairment of endothelial structure and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356067     DOI: 10.1210/jc.2003-031867

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  59 in total

1.  Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.

Authors:  Yi-fei Zhang; Yi-sheng Yang; Jie Hong; Wei-qiong Gu; Chun-fang Shen; Min Xu; Peng-fei Du; Xiao-ying Li; Guang Ning
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

Review 2.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

3.  Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Authors:  Rebeccah A McKibben; Mahmoud Al Rifai; Lena M Mathews; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-12-29

4.  Birth weight and childhood growth in daughters of women with irregular menstrual cycles.

Authors:  Erica T Wang; Piera M Cirillo; Chia-Ning Kao; Barbara A Cohn; Marcelle I Cedars
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

5.  Varying patterns of brachial artery flow-mediated dilatation in women with polycystic ovary syndrome and controls: An application of the group-based trajectory modeling.

Authors:  Michelle L Meyer; Ping G Tepper; Emma Barinas-Mitchell; Mary T Korytkowski; Evelyn O Talbott
Journal:  J Clin Ultrasound       Date:  2015-07-14       Impact factor: 0.910

Review 6.  The metabolic syndrome in polycystic ovary syndrome.

Authors:  P A Essah; J E Nestler
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

7.  Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  Life Sci       Date:  2014-03-05       Impact factor: 5.037

8.  Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women.

Authors:  Ayse Kargili; Feridun Karakurt; Benan Kasapoglu; Aysel Derbent; Cemile Koca; Yusuf Selcoki
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

9.  Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.

Authors:  Giuseppe Loverro; Giovanni De Pergola; Edoardo Di Naro; Massimo Tartagni; Cristina Lavopa; Anna Maria Caringella
Journal:  J Ovarian Res       Date:  2010-11-09       Impact factor: 4.234

10.  Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.

Authors:  Stefano Palomba; Angela Falbo; Francesco Giallauria; Tiziana Russo; Achille Tolino; Fulvio Zullo; Annamaria Colao; Francesco Orio
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.